nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Epirubicin—thyroid cancer	0.493	0.653	CbGbCtD
Dexrazoxane—TOP2A—Doxorubicin—thyroid cancer	0.262	0.347	CbGbCtD
Dexrazoxane—TOP2B—saliva-secreting gland—thyroid cancer	0.00273	0.248	CbGeAlD
Dexrazoxane—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.0026	0.312	CbGdCrCtD
Dexrazoxane—TOP2B—trachea—thyroid cancer	0.00211	0.191	CbGeAlD
Dexrazoxane—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.0017	0.204	CbGdCrCtD
Dexrazoxane—TOP2B—thyroid gland—thyroid cancer	0.00167	0.151	CbGeAlD
Dexrazoxane—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.00148	0.178	CbGdCrCtD
Dexrazoxane—TOP2B—head—thyroid cancer	0.00148	0.134	CbGeAlD
Dexrazoxane—Myelosuppression—Epirubicin—thyroid cancer	0.00144	0.0064	CcSEcCtD
Dexrazoxane—Haemoglobin—Vandetanib—thyroid cancer	0.00137	0.00608	CcSEcCtD
Dexrazoxane—Haemorrhage—Vandetanib—thyroid cancer	0.00136	0.00605	CcSEcCtD
Dexrazoxane—Myelosuppression—Doxorubicin—thyroid cancer	0.00134	0.00592	CcSEcCtD
Dexrazoxane—Hyponatraemia—Sorafenib—thyroid cancer	0.00134	0.00592	CcSEcCtD
Dexrazoxane—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.00132	0.00587	CcSEcCtD
Dexrazoxane—Cardiac disorder—Vandetanib—thyroid cancer	0.00127	0.00561	CcSEcCtD
Dexrazoxane—Angiopathy—Vandetanib—thyroid cancer	0.00124	0.00549	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Vandetanib—thyroid cancer	0.00123	0.00545	CcSEcCtD
Dexrazoxane—TOP2A—thyroid gland—thyroid cancer	0.00123	0.111	CbGeAlD
Dexrazoxane—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.00122	0.00543	CcSEcCtD
Dexrazoxane—Alopecia—Vandetanib—thyroid cancer	0.00121	0.00534	CcSEcCtD
Dexrazoxane—Breast disorder—Sorafenib—thyroid cancer	0.0012	0.00533	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.0012	0.00531	CcSEcCtD
Dexrazoxane—Mental disorder—Vandetanib—thyroid cancer	0.00119	0.0053	CcSEcCtD
Dexrazoxane—Malnutrition—Vandetanib—thyroid cancer	0.00119	0.00526	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00117	0.0052	CcSEcCtD
Dexrazoxane—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.00116	0.00516	CcSEcCtD
Dexrazoxane—Dysphagia—Sorafenib—thyroid cancer	0.00115	0.0051	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Epirubicin—thyroid cancer	0.00113	0.00499	CcSEcCtD
Dexrazoxane—Tremor—Vandetanib—thyroid cancer	0.00111	0.00493	CcSEcCtD
Dexrazoxane—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.00108	0.00478	CcSEcCtD
Dexrazoxane—Neutropenia—Sorafenib—thyroid cancer	0.00107	0.00477	CcSEcCtD
Dexrazoxane—Loss of consciousness—Vandetanib—thyroid cancer	0.00104	0.00463	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Doxorubicin—thyroid cancer	0.00104	0.00462	CcSEcCtD
Dexrazoxane—Weight decreased—Sorafenib—thyroid cancer	0.00104	0.00461	CcSEcCtD
Dexrazoxane—TOP2B—lymph node—thyroid cancer	0.00104	0.0941	CbGeAlD
Dexrazoxane—Cough—Vandetanib—thyroid cancer	0.00104	0.00459	CcSEcCtD
Dexrazoxane—Pneumonia—Sorafenib—thyroid cancer	0.00103	0.00457	CcSEcCtD
Dexrazoxane—Infestation—Sorafenib—thyroid cancer	0.00102	0.00454	CcSEcCtD
Dexrazoxane—Infestation NOS—Sorafenib—thyroid cancer	0.00102	0.00454	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.001	0.00445	CcSEcCtD
Dexrazoxane—Stomatitis—Sorafenib—thyroid cancer	0.000999	0.00443	CcSEcCtD
Dexrazoxane—Dry mouth—Vandetanib—thyroid cancer	0.000988	0.00438	CcSEcCtD
Dexrazoxane—Hypercalcaemia—Epirubicin—thyroid cancer	0.000974	0.00432	CcSEcCtD
Dexrazoxane—Infection—Vandetanib—thyroid cancer	0.000963	0.00427	CcSEcCtD
Dexrazoxane—Nervous system disorder—Vandetanib—thyroid cancer	0.00095	0.00421	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vandetanib—thyroid cancer	0.000949	0.00421	CcSEcCtD
Dexrazoxane—Skin disorder—Vandetanib—thyroid cancer	0.000941	0.00417	CcSEcCtD
Dexrazoxane—Haemoglobin—Sorafenib—thyroid cancer	0.000925	0.0041	CcSEcCtD
Dexrazoxane—Haemorrhage—Sorafenib—thyroid cancer	0.00092	0.00408	CcSEcCtD
Dexrazoxane—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.000915	0.00406	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Sorafenib—thyroid cancer	0.000904	0.00401	CcSEcCtD
Dexrazoxane—Hypercalcaemia—Doxorubicin—thyroid cancer	0.000902	0.004	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000883	0.00391	CcSEcCtD
Dexrazoxane—Insomnia—Vandetanib—thyroid cancer	0.000876	0.00389	CcSEcCtD
Dexrazoxane—Dyspnoea—Vandetanib—thyroid cancer	0.000864	0.00383	CcSEcCtD
Dexrazoxane—Cardiac disorder—Sorafenib—thyroid cancer	0.000854	0.00379	CcSEcCtD
Dexrazoxane—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.000846	0.00375	CcSEcCtD
Dexrazoxane—Decreased appetite—Vandetanib—thyroid cancer	0.000842	0.00373	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000836	0.00371	CcSEcCtD
Dexrazoxane—Fatigue—Vandetanib—thyroid cancer	0.000835	0.0037	CcSEcCtD
Dexrazoxane—Angiopathy—Sorafenib—thyroid cancer	0.000835	0.0037	CcSEcCtD
Dexrazoxane—Injection site pain—Epirubicin—thyroid cancer	0.000829	0.00368	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Sorafenib—thyroid cancer	0.000829	0.00368	CcSEcCtD
Dexrazoxane—Constipation—Vandetanib—thyroid cancer	0.000829	0.00367	CcSEcCtD
Dexrazoxane—Pain—Vandetanib—thyroid cancer	0.000829	0.00367	CcSEcCtD
Dexrazoxane—Alopecia—Sorafenib—thyroid cancer	0.000813	0.0036	CcSEcCtD
Dexrazoxane—Mental disorder—Sorafenib—thyroid cancer	0.000806	0.00357	CcSEcCtD
Dexrazoxane—Malnutrition—Sorafenib—thyroid cancer	0.000801	0.00355	CcSEcCtD
Dexrazoxane—Erythema—Sorafenib—thyroid cancer	0.000801	0.00355	CcSEcCtD
Dexrazoxane—Neoplasm malignant—Epirubicin—thyroid cancer	0.000793	0.00352	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000792	0.00351	CcSEcCtD
Dexrazoxane—Extravasation—Epirubicin—thyroid cancer	0.000776	0.00344	CcSEcCtD
Dexrazoxane—Injection site pain—Doxorubicin—thyroid cancer	0.000767	0.0034	CcSEcCtD
Dexrazoxane—Abdominal pain—Vandetanib—thyroid cancer	0.000766	0.0034	CcSEcCtD
Dexrazoxane—Body temperature increased—Vandetanib—thyroid cancer	0.000766	0.0034	CcSEcCtD
Dexrazoxane—TOP2A—lymph node—thyroid cancer	0.000762	0.0692	CbGeAlD
Dexrazoxane—Anaemia—Sorafenib—thyroid cancer	0.00074	0.00328	CcSEcCtD
Dexrazoxane—Neoplasm malignant—Doxorubicin—thyroid cancer	0.000734	0.00325	CcSEcCtD
Dexrazoxane—Syncope—Sorafenib—thyroid cancer	0.000718	0.00318	CcSEcCtD
Dexrazoxane—Extravasation—Doxorubicin—thyroid cancer	0.000718	0.00318	CcSEcCtD
Dexrazoxane—Leukopenia—Sorafenib—thyroid cancer	0.000717	0.00318	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Epirubicin—thyroid cancer	0.000716	0.00317	CcSEcCtD
Dexrazoxane—Creatinine increased—Epirubicin—thyroid cancer	0.000711	0.00315	CcSEcCtD
Dexrazoxane—Loss of consciousness—Sorafenib—thyroid cancer	0.000704	0.00312	CcSEcCtD
Dexrazoxane—Cough—Sorafenib—thyroid cancer	0.000699	0.0031	CcSEcCtD
Dexrazoxane—Asthenia—Vandetanib—thyroid cancer	0.000695	0.00308	CcSEcCtD
Dexrazoxane—Pruritus—Vandetanib—thyroid cancer	0.000685	0.00304	CcSEcCtD
Dexrazoxane—Myalgia—Sorafenib—thyroid cancer	0.000682	0.00302	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000677	0.003	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000677	0.003	CcSEcCtD
Dexrazoxane—Injection site reaction—Epirubicin—thyroid cancer	0.000673	0.00298	CcSEcCtD
Dexrazoxane—Dry mouth—Sorafenib—thyroid cancer	0.000667	0.00296	CcSEcCtD
Dexrazoxane—Diarrhoea—Vandetanib—thyroid cancer	0.000663	0.00294	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000662	0.00294	CcSEcCtD
Dexrazoxane—Creatinine increased—Doxorubicin—thyroid cancer	0.000658	0.00292	CcSEcCtD
Dexrazoxane—Infection—Sorafenib—thyroid cancer	0.000649	0.00288	CcSEcCtD
Dexrazoxane—Shock—Sorafenib—thyroid cancer	0.000643	0.00285	CcSEcCtD
Dexrazoxane—Nervous system disorder—Sorafenib—thyroid cancer	0.000641	0.00284	CcSEcCtD
Dexrazoxane—Dizziness—Vandetanib—thyroid cancer	0.000641	0.00284	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Sorafenib—thyroid cancer	0.00064	0.00284	CcSEcCtD
Dexrazoxane—Skin disorder—Sorafenib—thyroid cancer	0.000635	0.00281	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000626	0.00278	CcSEcCtD
Dexrazoxane—Anorexia—Sorafenib—thyroid cancer	0.000623	0.00276	CcSEcCtD
Dexrazoxane—Injection site reaction—Doxorubicin—thyroid cancer	0.000623	0.00276	CcSEcCtD
Dexrazoxane—Oesophagitis—Epirubicin—thyroid cancer	0.000619	0.00274	CcSEcCtD
Dexrazoxane—Vomiting—Vandetanib—thyroid cancer	0.000616	0.00273	CcSEcCtD
Dexrazoxane—Headache—Vandetanib—thyroid cancer	0.000607	0.00269	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000595	0.00264	CcSEcCtD
Dexrazoxane—Sepsis—Epirubicin—thyroid cancer	0.000587	0.0026	CcSEcCtD
Dexrazoxane—Dyspnoea—Sorafenib—thyroid cancer	0.000583	0.00258	CcSEcCtD
Dexrazoxane—Nausea—Vandetanib—thyroid cancer	0.000575	0.00255	CcSEcCtD
Dexrazoxane—Oesophagitis—Doxorubicin—thyroid cancer	0.000572	0.00254	CcSEcCtD
Dexrazoxane—Phlebitis—Epirubicin—thyroid cancer	0.00057	0.00253	CcSEcCtD
Dexrazoxane—Decreased appetite—Sorafenib—thyroid cancer	0.000568	0.00252	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000565	0.00251	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000564	0.0025	CcSEcCtD
Dexrazoxane—Fatigue—Sorafenib—thyroid cancer	0.000563	0.0025	CcSEcCtD
Dexrazoxane—Pain—Sorafenib—thyroid cancer	0.000559	0.00248	CcSEcCtD
Dexrazoxane—Constipation—Sorafenib—thyroid cancer	0.000559	0.00248	CcSEcCtD
Dexrazoxane—Sepsis—Doxorubicin—thyroid cancer	0.000544	0.00241	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000542	0.0024	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000534	0.00237	CcSEcCtD
Dexrazoxane—Phlebitis—Doxorubicin—thyroid cancer	0.000528	0.00234	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000523	0.00232	CcSEcCtD
Dexrazoxane—Urticaria—Sorafenib—thyroid cancer	0.000519	0.0023	CcSEcCtD
Dexrazoxane—Abdominal pain—Sorafenib—thyroid cancer	0.000517	0.00229	CcSEcCtD
Dexrazoxane—Body temperature increased—Sorafenib—thyroid cancer	0.000517	0.00229	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000501	0.00222	CcSEcCtD
Dexrazoxane—Hyponatraemia—Epirubicin—thyroid cancer	0.000493	0.00219	CcSEcCtD
Dexrazoxane—Asthenia—Sorafenib—thyroid cancer	0.000469	0.00208	CcSEcCtD
Dexrazoxane—Pruritus—Sorafenib—thyroid cancer	0.000462	0.00205	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Epirubicin—thyroid cancer	0.00046	0.00204	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—thyroid cancer	0.000457	0.00202	CcSEcCtD
Dexrazoxane—Diarrhoea—Sorafenib—thyroid cancer	0.000447	0.00198	CcSEcCtD
Dexrazoxane—Breast disorder—Epirubicin—thyroid cancer	0.000444	0.00197	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000443	0.00196	CcSEcCtD
Dexrazoxane—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	0.000441	0.0529	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	0.000441	0.0529	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Epirubicin—thyroid cancer	0.000441	0.0529	CbGdCrCtD
Dexrazoxane—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000433	0.00192	CcSEcCtD
Dexrazoxane—Dizziness—Sorafenib—thyroid cancer	0.000432	0.00192	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000426	0.00189	CcSEcCtD
Dexrazoxane—Dysphagia—Epirubicin—thyroid cancer	0.000425	0.00188	CcSEcCtD
Dexrazoxane—Vomiting—Sorafenib—thyroid cancer	0.000416	0.00184	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—thyroid cancer	0.000411	0.00182	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000409	0.00182	CcSEcCtD
Dexrazoxane—Headache—Sorafenib—thyroid cancer	0.000409	0.00182	CcSEcCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	0.000408	0.049	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	0.000408	0.049	CbGdCrCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	0.000408	0.049	CbGdCrCtD
Dexrazoxane—Pancytopenia—Epirubicin—thyroid cancer	0.000403	0.00179	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000401	0.00178	CcSEcCtD
Dexrazoxane—Neutropenia—Epirubicin—thyroid cancer	0.000397	0.00176	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—thyroid cancer	0.000393	0.00174	CcSEcCtD
Dexrazoxane—Nausea—Sorafenib—thyroid cancer	0.000388	0.00172	CcSEcCtD
Dexrazoxane—Weight decreased—Epirubicin—thyroid cancer	0.000384	0.0017	CcSEcCtD
Dexrazoxane—Pneumonia—Epirubicin—thyroid cancer	0.000381	0.00169	CcSEcCtD
Dexrazoxane—Infestation—Epirubicin—thyroid cancer	0.000379	0.00168	CcSEcCtD
Dexrazoxane—Infestation NOS—Epirubicin—thyroid cancer	0.000379	0.00168	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—thyroid cancer	0.000373	0.00165	CcSEcCtD
Dexrazoxane—Stomatitis—Epirubicin—thyroid cancer	0.000369	0.00164	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—thyroid cancer	0.000367	0.00163	CcSEcCtD
Dexrazoxane—Weight decreased—Doxorubicin—thyroid cancer	0.000356	0.00158	CcSEcCtD
Dexrazoxane—Agranulocytosis—Epirubicin—thyroid cancer	0.000353	0.00157	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—thyroid cancer	0.000352	0.00156	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—thyroid cancer	0.00035	0.00155	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—thyroid cancer	0.00035	0.00155	CcSEcCtD
Dexrazoxane—Haemoglobin—Epirubicin—thyroid cancer	0.000342	0.00152	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—thyroid cancer	0.000342	0.00151	CcSEcCtD
Dexrazoxane—Haemorrhage—Epirubicin—thyroid cancer	0.00034	0.00151	CcSEcCtD
Dexrazoxane—Oedema peripheral—Epirubicin—thyroid cancer	0.000335	0.00148	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Epirubicin—thyroid cancer	0.000334	0.00148	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—thyroid cancer	0.000327	0.00145	CcSEcCtD
Dexrazoxane—Haemoglobin—Doxorubicin—thyroid cancer	0.000316	0.0014	CcSEcCtD
Dexrazoxane—Cardiac disorder—Epirubicin—thyroid cancer	0.000316	0.0014	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—thyroid cancer	0.000315	0.00139	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—thyroid cancer	0.00031	0.00137	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000309	0.00137	CcSEcCtD
Dexrazoxane—Angiopathy—Epirubicin—thyroid cancer	0.000308	0.00137	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Epirubicin—thyroid cancer	0.000306	0.00136	CcSEcCtD
Dexrazoxane—Alopecia—Epirubicin—thyroid cancer	0.0003	0.00133	CcSEcCtD
Dexrazoxane—Mental disorder—Epirubicin—thyroid cancer	0.000298	0.00132	CcSEcCtD
Dexrazoxane—Malnutrition—Epirubicin—thyroid cancer	0.000296	0.00131	CcSEcCtD
Dexrazoxane—Erythema—Epirubicin—thyroid cancer	0.000296	0.00131	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—thyroid cancer	0.000292	0.00129	CcSEcCtD
Dexrazoxane—Angiopathy—Doxorubicin—thyroid cancer	0.000285	0.00127	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000284	0.00126	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—thyroid cancer	0.000278	0.00123	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—thyroid cancer	0.000276	0.00122	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Epirubicin—thyroid cancer	0.000275	0.00122	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—thyroid cancer	0.000274	0.00121	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—thyroid cancer	0.000274	0.00121	CcSEcCtD
Dexrazoxane—Anaemia—Epirubicin—thyroid cancer	0.000274	0.00121	CcSEcCtD
Dexrazoxane—Malaise—Epirubicin—thyroid cancer	0.000267	0.00118	CcSEcCtD
Dexrazoxane—Syncope—Epirubicin—thyroid cancer	0.000265	0.00118	CcSEcCtD
Dexrazoxane—Leukopenia—Epirubicin—thyroid cancer	0.000265	0.00117	CcSEcCtD
Dexrazoxane—Loss of consciousness—Epirubicin—thyroid cancer	0.00026	0.00115	CcSEcCtD
Dexrazoxane—Cough—Epirubicin—thyroid cancer	0.000258	0.00115	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000254	0.00113	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—thyroid cancer	0.000253	0.00112	CcSEcCtD
Dexrazoxane—Myalgia—Epirubicin—thyroid cancer	0.000252	0.00112	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00025	0.00111	CcSEcCtD
Dexrazoxane—Discomfort—Epirubicin—thyroid cancer	0.000249	0.0011	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—thyroid cancer	0.000247	0.00109	CcSEcCtD
Dexrazoxane—Dry mouth—Epirubicin—thyroid cancer	0.000246	0.00109	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—thyroid cancer	0.000246	0.00109	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—thyroid cancer	0.000245	0.00109	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—thyroid cancer	0.000241	0.00107	CcSEcCtD
Dexrazoxane—Infection—Epirubicin—thyroid cancer	0.00024	0.00106	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—thyroid cancer	0.000239	0.00106	CcSEcCtD
Dexrazoxane—Shock—Epirubicin—thyroid cancer	0.000238	0.00105	CcSEcCtD
Dexrazoxane—Nervous system disorder—Epirubicin—thyroid cancer	0.000237	0.00105	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Epirubicin—thyroid cancer	0.000236	0.00105	CcSEcCtD
Dexrazoxane—Skin disorder—Epirubicin—thyroid cancer	0.000235	0.00104	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—thyroid cancer	0.000233	0.00103	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000232	0.00103	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—thyroid cancer	0.00023	0.00102	CcSEcCtD
Dexrazoxane—Anorexia—Epirubicin—thyroid cancer	0.00023	0.00102	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—thyroid cancer	0.000228	0.00101	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—thyroid cancer	0.000222	0.000984	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00022	0.000976	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—thyroid cancer	0.00022	0.000975	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—thyroid cancer	0.000219	0.000972	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000219	0.00097	CcSEcCtD
Dexrazoxane—Insomnia—Epirubicin—thyroid cancer	0.000218	0.000969	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—thyroid cancer	0.000217	0.000962	CcSEcCtD
Dexrazoxane—Dyspnoea—Epirubicin—thyroid cancer	0.000215	0.000955	CcSEcCtD
Dexrazoxane—Somnolence—Epirubicin—thyroid cancer	0.000215	0.000952	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—thyroid cancer	0.000213	0.000945	CcSEcCtD
Dexrazoxane—Decreased appetite—Epirubicin—thyroid cancer	0.00021	0.000931	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000209	0.000925	CcSEcCtD
Dexrazoxane—Fatigue—Epirubicin—thyroid cancer	0.000208	0.000923	CcSEcCtD
Dexrazoxane—Pain—Epirubicin—thyroid cancer	0.000207	0.000916	CcSEcCtD
Dexrazoxane—Constipation—Epirubicin—thyroid cancer	0.000207	0.000916	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000204	0.000903	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—thyroid cancer	0.000202	0.000896	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—thyroid cancer	0.000199	0.000883	CcSEcCtD
Dexrazoxane—Feeling abnormal—Epirubicin—thyroid cancer	0.000199	0.000883	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—thyroid cancer	0.000199	0.000881	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000198	0.000876	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—thyroid cancer	0.000194	0.000861	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000193	0.000855	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—thyroid cancer	0.000193	0.000854	CcSEcCtD
Dexrazoxane—Urticaria—Epirubicin—thyroid cancer	0.000192	0.000851	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—thyroid cancer	0.000191	0.000847	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—thyroid cancer	0.000191	0.000847	CcSEcCtD
Dexrazoxane—Abdominal pain—Epirubicin—thyroid cancer	0.000191	0.000847	CcSEcCtD
Dexrazoxane—Body temperature increased—Epirubicin—thyroid cancer	0.000191	0.000847	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—thyroid cancer	0.000184	0.000817	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000183	0.00081	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—thyroid cancer	0.000178	0.000787	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—thyroid cancer	0.000177	0.000783	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—thyroid cancer	0.000177	0.000783	CcSEcCtD
Dexrazoxane—Asthenia—Epirubicin—thyroid cancer	0.000173	0.000768	CcSEcCtD
Dexrazoxane—Pruritus—Epirubicin—thyroid cancer	0.000171	0.000758	CcSEcCtD
Dexrazoxane—Diarrhoea—Epirubicin—thyroid cancer	0.000165	0.000733	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—thyroid cancer	0.00016	0.000711	CcSEcCtD
Dexrazoxane—Dizziness—Epirubicin—thyroid cancer	0.00016	0.000708	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—thyroid cancer	0.000158	0.000701	CcSEcCtD
Dexrazoxane—Vomiting—Epirubicin—thyroid cancer	0.000154	0.000681	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—thyroid cancer	0.000153	0.000678	CcSEcCtD
Dexrazoxane—Headache—Epirubicin—thyroid cancer	0.000151	0.000671	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—thyroid cancer	0.000148	0.000655	CcSEcCtD
Dexrazoxane—Nausea—Epirubicin—thyroid cancer	0.000143	0.000636	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—thyroid cancer	0.000142	0.00063	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—thyroid cancer	0.00014	0.000621	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—thyroid cancer	0.000133	0.000589	CcSEcCtD
